Cryoport planned sale of 28,800 common shares

Cryoport, Inc. disclosed a planned sale of up to 28,800 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an aggregate value of $426,816.00 as of 08/11/2026.

Accepted by SEC EDGAR 08/11/2026 - 04:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Cryoport, Inc. disclosed a planned sale of up to 28,800 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an aggregate value of $426,816.00 as of 08/11/2026. The shares come from restricted stock units and previously exercised holdings acquired on 02/29/2012.

Key Figures

Shares planned for sale: 28,800 shares Aggregate value of shares: $426,816.00 Acquisition date of underlying shares: 02/29/2012 +1 more

4 metrics

Shares planned for sale 28,800 shares Common stock planned for sale through Morgan Stanley Smith Barney LLC Executive Financial Services

Aggregate value of shares $426,816.00 Aggregate value associated with 28,800 common shares as of 08/11/2026

Acquisition date of underlying shares 02/29/2012 Date shares from restricted stock units and prior exercises were acquired

Planned sale date 08/11/2026 Date tied to the proposed NASDAQ sale of common shares

Key Terms

Restricted Stock Units, Previously Exercised and Hold, Executive Financial Services

3 terms

Restricted Stock Units financial

"Common | 02/29/2012 | Restricted Stock Units and Previously Exercised"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Previously Exercised and Hold financial

"Restricted Stock Units and Previously Exercised and Hold | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is Cryoport (CYRX) planning under this Form 144?

Cryoport is planning a potential sale of up to 28,800 common shares on NASDAQ. The planned sale has an aggregate value of $426,816.00 as of 08/11/2026, based on the disclosure details provided.

What type of Cryoport (CYRX) securities are involved in the 28,800-share sale?

The planned sale involves common stock of Cryoport, Inc. These shares originate from restricted stock units and previously exercised and held shares that were acquired on 02/29/2012, according to the disclosure.

What is the disclosed market value of the Cryoport (CYRX) shares to be sold?

The planned sale of Cryoport shares has a disclosed aggregate market value of $426,816.00. This value is tied to the planned sale of 28,800 common shares on 08/11/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

On which market will the Cryoport (CYRX) shares be sold and through whom?

The Cryoport common shares are planned to be sold on the NASDAQ market. The sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, as specified in the transaction details.

When were the Cryoport (CYRX) shares scheduled for sale originally acquired?

The shares scheduled for potential sale were originally acquired on 02/29/2012. They arise from restricted stock units and previously exercised and held shares, which are now being listed for potential sale under the disclosed plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001283212
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CRYOPORT INC
SEC File Number	001-34632
Address of Issuer	112 Westwood Place, Suite 350 Brentwood TENNESSEE 37027
Phone	9494702300
Name of Person for Whose Account the Securities are To Be Sold	JERRELL W SHELTON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28800	426816.00	50649100	08/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/29/2012	Restricted Stock Units and Previously Exercised and Hold	Issuer			28800	02/29/2012	N/A and Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of Restricted Stock Units and Previously Exercised and Hold during the period of 02/29/2012 through 11/22/2024.
Date of Notice	08/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jerrell W Shelton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)